Search





Search





Novocure Ltd

NVCR

Add to Watchlist

16.950USD

-0.430-2.47%

Close 08-14 16:00（ET）Quotes delayed by 15 min

1.97BMarket Cap

LossP/E TTM

Novocure Ltd

16.950

-0.430-2.47%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

NVCR Analysis

Review the valuation, outlook, chart signals and key risks shaping Novocure Ltd stock.

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

TradingKeyFri, Jul 24